Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

IRIX vs LASE vs ARAY vs NPKI vs ISRG

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IRIX
IRIDEX Corporation

Medical - Devices

HealthcareNASDAQ • US
Market Cap$18M
5Y Perf.-42.5%
LASE
Laser Photonics Corporation

Industrial - Machinery

IndustrialsNASDAQ • US
Market Cap$19M
5Y Perf.-84.4%
ARAY
Accuray Incorporated

Medical - Devices

HealthcareNASDAQ • US
Market Cap$45M
5Y Perf.-83.0%
NPKI
NPK International Inc.

Oil & Gas Equipment & Services

EnergyNYSE • US
Market Cap$1.26B
5Y Perf.+78.8%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$159.85B
5Y Perf.-17.0%

IRIX vs LASE vs ARAY vs NPKI vs ISRG — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IRIX logoIRIX
LASE logoLASE
ARAY logoARAY
NPKI logoNPKI
ISRG logoISRG
IndustryMedical - DevicesIndustrial - MachineryMedical - DevicesOil & Gas Equipment & ServicesMedical - Instruments & Supplies
Market Cap$18M$19M$45M$1.26B$159.85B
Revenue (TTM)$51M$7M$429M$287M$10.58B
Net Income (TTM)$-5M$-8M$-46M$36M$2.98B
Gross Margin38.0%31.1%26.8%35.2%66.3%
Operating Margin-6.0%-126.5%-3.5%11.4%30.5%
Forward P/E28.1x43.3x
Total Debt$5M$5M$176M$37M$303M
Cash & Equiv.$2M$534K$57M$5M$3.37B

IRIX vs LASE vs ARAY vs NPKI vs ISRGLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IRIX
LASE
ARAY
NPKI
ISRG
StockNov 24May 26Return
IRIDEX Corporation (IRIX)10057.5-42.5%
Laser Photonics Cor… (LASE)10015.6-84.4%
Accuray Incorporated (ARAY)10017.0-83.0%
NPK International I… (NPKI)100178.8+78.8%
Intuitive Surgical,… (ISRG)10083.0-17.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: IRIX vs LASE vs ARAY vs NPKI vs ISRG

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: NPKI and ISRG are tied at the top with 3 categories each (5-stock set) — the right choice depends on your priorities. Intuitive Surgical, Inc. is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
IRIX
IRIDEX Corporation
The Healthcare Pick

IRIX plays a supporting role in this comparison — it may shine differently against other peers.

Best for: healthcare exposure
LASE
Laser Photonics Corporation
The Income Pick

LASE is the clearest fit if your priority is income & stability.

  • Dividend streak 2 yrs, beta 1.81
Best for: income & stability
ARAY
Accuray Incorporated
The Healthcare Pick

Among these 5 stocks, ARAY doesn't own a clear edge in any measured category.

Best for: healthcare exposure
NPKI
NPK International Inc.
The Growth Play

NPKI carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 27.4%, EPS growth 124.0%, 3Y rev CAGR 12.8%
  • 27.4% revenue growth vs LASE's -13.3%
  • Lower P/E (28.1x vs 43.3x)
  • +85.5% vs ARAY's -74.5%
Best for: growth exposure
ISRG
Intuitive Surgical, Inc.
The Long-Run Compounder

ISRG is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.

  • 5.5% 10Y total return vs NPKI's 85.5%
  • Lower volatility, beta 1.00, Low D/E 1.7%, current ratio 4.87x
  • Beta 1.00, current ratio 4.87x
  • 28.2% margin vs LASE's -105.4%
Best for: long-term compounding and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthNPKI logoNPKI27.4% revenue growth vs LASE's -13.3%
ValueNPKI logoNPKILower P/E (28.1x vs 43.3x)
Quality / MarginsISRG logoISRG28.2% margin vs LASE's -105.4%
Stability / SafetyISRG logoISRGBeta 1.00 vs ARAY's 2.66, lower leverage
DividendsTieNone of these 5 stocks pay a meaningful dividend
Momentum (1Y)NPKI logoNPKI+85.5% vs ARAY's -74.5%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs LASE's -43.1%, ROIC 15.0% vs -42.1%

IRIX vs LASE vs ARAY vs NPKI vs ISRG — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IRIXIRIDEX Corporation
FY 2024
Retina
57.2%$28M
Cyclo G Six
26.1%$13M
Product and Service, Other
16.7%$8M
LASELaser Photonics Corporation

Segment breakdown not available.

ARAYAccuray Incorporated
FY 2025
Product
51.8%$238M
Service
48.2%$221M
NPKINPK International Inc.
FY 2025
Rental and Service
66.3%$184M
Product
33.7%$93M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B

IRIX vs LASE vs ARAY vs NPKI vs ISRG — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGIRIX

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 4 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 1482.0x LASE's $7M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to LASE's -105.4%. On growth, LASE holds the edge at +28.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…NPKI logoNPKINPK International…ISRG logoISRGIntuitive Surgica…
RevenueTrailing 12 months$51M$7M$429M$287M$10.6B
EBITDAEarnings before interest/tax-$2M-$8M-$6M$53M$3.8B
Net IncomeAfter-tax profit-$5M-$8M-$46M$36M$3.0B
Free Cash FlowCash after capex-$3M-$4M-$29M$32M$2.8B
Gross MarginGross profit ÷ Revenue+38.0%+31.1%+26.8%+35.2%+66.3%
Operating MarginEBIT ÷ Revenue-6.0%-126.5%-3.5%+11.4%+30.5%
Net MarginNet income ÷ Revenue-10.0%-105.4%-10.8%+12.4%+28.2%
FCF MarginFCF ÷ Revenue-5.6%-58.7%-6.8%+11.1%+26.8%
Rev. Growth (YoY)Latest quarter vs prior year+7.8%+28.3%-7.4%+15.9%+23.0%
EPS Growth (YoY)Latest quarter vs prior year+25.0%-7.4%-6.1%0.0%+18.8%
ISRG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

ARAY leads this category, winning 4 of 6 comparable metrics.

At 35.6x trailing earnings, NPKI trades at a 38% valuation discount to ISRG's 57.2x P/E. On an enterprise value basis, ARAY's 11.7x EV/EBITDA is more attractive than ISRG's 43.3x.

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…NPKI logoNPKINPK International…ISRG logoISRGIntuitive Surgica…
Market CapShares × price$18M$19M$45M$1.3B$159.8B
Enterprise ValueMkt cap + debt − cash$20M$24M$164M$1.3B$156.8B
Trailing P/EPrice ÷ TTM EPS-1.91x-3.97x-24.52x35.60x57.19x
Forward P/EPrice ÷ next-FY EPS est.28.08x43.35x
PEG RatioP/E ÷ EPS growth rate2.63x
EV / EBITDAEnterprise value multiple11.74x17.92x43.28x
Price / SalesMarket cap ÷ Revenue0.36x5.68x0.10x4.56x15.88x
Price / BookPrice ÷ Book value/share8.07x1.08x0.48x3.65x9.10x
Price / FCFMarket cap ÷ FCF48.02x64.18x
ARAY leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 6 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-184 for LASE. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRIX's 2.21x. On the Piotroski fundamental quality scale (0–9), NPKI scores 7/9 vs LASE's 1/9, reflecting strong financial health.

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…NPKI logoNPKINPK International…ISRG logoISRGIntuitive Surgica…
ROE (TTM)Return on equity-108.7%-183.5%-77.5%+10.3%+16.9%
ROA (TTM)Return on assets-17.9%-43.1%-10.1%+8.5%+14.8%
ROICReturn on invested capital-129.9%-42.1%+3.0%+9.9%+15.0%
ROCEReturn on capital employed-48.8%-45.9%+2.8%+12.7%+16.5%
Piotroski ScoreFundamental quality 0–921676
Debt / EquityFinancial leverage2.21x0.49x2.17x0.10x0.02x
Net DebtTotal debt minus cash$2M$4M$119M$31M-$3.1B
Cash & Equiv.Liquid assets$2M$533,871$57M$5M$3.4B
Total DebtShort + long-term debt$5M$5M$176M$37M$303M
Interest CoverageEBIT ÷ Interest expense-6.60x-0.54x77.08x
ISRG leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

NPKI leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in NPKI five years ago would be worth $18,548 today (with dividends reinvested), compared to $880 for ARAY. Over the past 12 months, NPKI leads with a +85.5% total return vs ARAY's -74.5%. The 3-year compound annual growth rate (CAGR) favors NPKI at 22.9% vs ARAY's -52.7% — a key indicator of consistent wealth creation.

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…NPKI logoNPKINPK International…ISRG logoISRGIntuitive Surgica…
YTD ReturnYear-to-date-12.0%-56.3%-55.3%+23.6%-19.9%
1-Year ReturnPast 12 months-9.6%-69.6%-74.5%+85.5%-16.4%
3-Year ReturnCumulative with dividends-54.6%-71.7%-89.4%+85.5%+48.5%
5-Year ReturnCumulative with dividends-86.2%-66.2%-91.2%+85.5%+61.7%
10-Year ReturnCumulative with dividends-90.8%-66.2%-92.8%+85.5%+549.2%
CAGR (3Y)Annualised 3-year return-23.2%-34.4%-52.7%+22.9%+14.1%
NPKI leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — NPKI and ISRG each lead in 1 of 2 comparable metrics.

ISRG is the less volatile stock with a 1.00 beta — it tends to amplify market swings less than ARAY's 2.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NPKI currently trades 90.6% from its 52-week high vs LASE's 12.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…NPKI logoNPKINPK International…ISRG logoISRGIntuitive Surgica…
Beta (5Y)Sensitivity to S&P 5001.16x1.81x2.66x1.27x1.00x
52-Week HighHighest price in past year$1.65$6.77$2.10$16.50$603.88
52-Week LowLowest price in past year$0.87$0.38$0.28$7.63$427.84
% of 52W HighCurrent price vs 52-week peak+62.4%+12.9%+18.1%+90.6%+74.5%
RSI (14)Momentum oscillator 0–10041.637.533.553.643.6
Avg Volume (50D)Average daily shares traded124K1.9M1.5M768K1.8M
Evenly matched — NPKI and ISRG each lead in 1 of 2 comparable metrics.

Analyst Outlook

LASE leads this category, winning 1 of 1 comparable metric.

Analyst consensus: NPKI as "Buy", ISRG as "Buy".

MetricIRIX logoIRIXIRIDEX CorporationLASE logoLASELaser Photonics C…ARAY logoARAYAccuray Incorpora…NPKI logoNPKINPK International…ISRG logoISRGIntuitive Surgica…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$622.60
# AnalystsCovering analysts355
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises20
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%+1.8%+1.4%
LASE leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ISRG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ARAY leads in 1 (Valuation Metrics). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 2 of 6 categories
Loading custom metrics...

IRIX vs LASE vs ARAY vs NPKI vs ISRG: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is IRIX or LASE or ARAY or NPKI or ISRG a better buy right now?

For growth investors, NPK International Inc.

(NPKI) is the stronger pick with 27. 4% revenue growth year-over-year, versus -13. 3% for Laser Photonics Corporation (LASE). NPK International Inc. (NPKI) offers the better valuation at 35. 6x trailing P/E (28. 1x forward), making it the more compelling value choice. Analysts rate NPK International Inc. (NPKI) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — IRIX or LASE or ARAY or NPKI or ISRG?

On trailing P/E, NPK International Inc.

(NPKI) is the cheapest at 35. 6x versus Intuitive Surgical, Inc. at 57. 2x. On forward P/E, NPK International Inc. is actually cheaper at 28. 1x.

03

Which is the better long-term investment — IRIX or LASE or ARAY or NPKI or ISRG?

Over the past 5 years, NPK International Inc.

(NPKI) delivered a total return of +85. 5%, compared to -91. 2% for Accuray Incorporated (ARAY). Over 10 years, the gap is even starker: ISRG returned +549. 2% versus ARAY's -92. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — IRIX or LASE or ARAY or NPKI or ISRG?

By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.

(ISRG) is the lower-risk stock at 1. 00β versus Accuray Incorporated's 2. 66β — meaning ARAY is approximately 166% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 2% for IRIDEX Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — IRIX or LASE or ARAY or NPKI or ISRG?

By revenue growth (latest reported year), NPK International Inc.

(NPKI) is pulling ahead at 27. 4% versus -13. 3% for Laser Photonics Corporation (LASE). On earnings-per-share growth, the picture is similar: NPK International Inc. grew EPS 124. 0% year-over-year, compared to 8. 5% for IRIDEX Corporation. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — IRIX or LASE or ARAY or NPKI or ISRG?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -73. 8% for Laser Photonics Corporation — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -189. 3% for LASE. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is IRIX or LASE or ARAY or NPKI or ISRG more undervalued right now?

On forward earnings alone, NPK International Inc.

(NPKI) trades at 28. 1x forward P/E versus 43. 3x for Intuitive Surgical, Inc. — 15. 3x cheaper on a one-year earnings basis.

08

Which pays a better dividend — IRIX or LASE or ARAY or NPKI or ISRG?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is IRIX or LASE or ARAY or NPKI or ISRG better for a retirement portfolio?

For long-horizon retirement investors, Intuitive Surgical, Inc.

(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), +549. 2% 10Y return). Accuray Incorporated (ARAY) carries a higher beta of 2. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +549. 2%, ARAY: -92. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between IRIX and LASE and ARAY and NPKI and ISRG?

These companies operate in different sectors (IRIX (Healthcare) and LASE (Industrials) and ARAY (Healthcare) and NPKI (Energy) and ISRG (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: IRIX is a small-cap quality compounder stock; LASE is a small-cap quality compounder stock; ARAY is a small-cap quality compounder stock; NPKI is a small-cap high-growth stock; ISRG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

IRIX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 22%
Run This Screen
Stocks Like

LASE

High-Growth Disruptor

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Gross Margin > 18%
Run This Screen
Stocks Like

ARAY

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 16%
Run This Screen
Stocks Like

NPKI

High-Growth Compounder

  • Sector: Energy
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 7%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform IRIX and LASE and ARAY and NPKI and ISRG on the metrics below

Revenue Growth>
%
(IRIX: 7.8% · LASE: 28.3%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.